We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
-$14.1B
Cap. Flow
-$21.4B
Cap. Flow %
-17.01%
Top 10 Hldgs %
26.03%
Holding
6,223
New
309
Increased
1,914
Reduced
2,674
Closed
469

Sector Composition

Rank Sector Weight
1 Technology 9.68%
2 Healthcare 6.62%
3 Financials 5.53%
4 Consumer Discretionary 5.08%
5 Industrials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATL icon
5401
Battalion Oil
BATL
$32.1M
$184 ﹤0.01%
19
-21
-53% -$249
BNNRW
5402
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$183 ﹤0.01%
12,151
SNCE
5403
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$180 ﹤0.01%
22
-42
-66% -$822
CDAK
5404
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$179 ﹤0.01%
449
+22
+5% +$14
AUTL
5405
Autolus Therapeutics
AUTL
$389M
$175 ﹤0.01%
92
-666
-88% -$1.68K
XOS icon
5406
Xos
XOS
$28.5M
$168 ﹤0.01%
13
-522
-98% -$13.4K
FATH
5407
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$165 ﹤0.01%
6
-2
-25% -$87
VTGN icon
5408
VistaGen Therapeutics
VTGN
$9.45M
$161 ﹤0.01%
52
-47
-47% -$177
KLR
5409
DELISTED
Kaleyra, Inc.
KLR
$161 ﹤0.01%
61
-66
-52% -$219
AOD
5410
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
$156 ﹤0.01%
20
RPID icon
5411
Rapid Micro Biosystems
RPID
$100M
$156 ﹤0.01%
138
-418
-75% -$1.01K
HOWL icon
5412
Werewolf Therapeutics
HOWL
$22M
$152 ﹤0.01%
74
-353
-83% -$923
ITQRW
5413
CALL
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$152 ﹤0.01%
19,001
PDN icon
5414
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$350M
$148 ﹤0.01%
+5
New +$141
SLYV icon
5415
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.9B
$148 ﹤0.01%
2
ADCT icon
5416
ADC Therapeutics
ADCT
$145M
$146 ﹤0.01%
38
+7
+23% +$28
ORBS
5417
Eightco Holdings
ORBS
$241M
$146 ﹤0.01%
3
-1
-25% -$113
RDHL
5418
Redhill Biopharma
RDHL
$4.26M
$146 ﹤0.01%
1
VIRX
5419
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$143 ﹤0.01%
98
-453
-82% -$1.32K
CRDF icon
5420
Cardiff Oncology
CRDF
$65M
$140 ﹤0.01%
+100
New +$143
NGNE icon
5421
Neurogene
NGNE
$691M
$137 ﹤0.01%
14
-25
-64% -$258
CORZ
5422
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$137 ﹤0.01%
1,830
-2,237
-55% -$1.03K
LFLY
5423
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$134 ﹤0.01%
10
-13
-57% -$189
HYZNW
5424
CALL
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$133 ﹤0.01%
+1,016
New +$203
ONCR
5425
DELISTED
Oncorus, Inc.
ONCR
$128 ﹤0.01%
506
+15
+3% +$9

Similar funds

Citigroup's Q4 2022 Portfolio in Review

As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.

  • Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
  • Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
  • Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
  • Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
  • Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
  • Citigroup opened 309 new positions and closed 469 in Q4 2022.
  • Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.